EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 50 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q4 2022. The put-call ratio across all filers is 55.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | – | 825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 632,138 | $6,208,000 | 2.45% |
| RP Investment Advisors LP | 1,100,000 | $10,802,000 | 1.51% |
| HGC Investment Management Inc. | 1,715,000 | $16,842,000 | 1.01% |
| Sage Rock Capital Management LP | 359,298 | $3,528,000 | 0.63% |
| MMCAP International Inc. SPC | 1,000,000 | $9,820,000 | 0.57% |
| Saba Capital Management, L.P. | 2,816,395 | $27,657,000 | 0.39% |
| CVI Holdings, LLC | 568,882 | $5,586,000 | 0.37% |
| Castle Creek Arbitrage, LLC | 728,652 | $7,148,000 | 0.36% |
| ARISTEIA CAPITAL, L.L.C. | 2,011,452 | $19,752,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 373,790 | $3,671,000 | 0.35% |